OTCMKTS:SBLOF Shin Nippon Biomedical Laboratories (SBLOF) Stock Price, News & Analysis $7.00 0.00 (0.00%) As of 10/12/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartNews and Trends About Shin Nippon Biomedical Laboratories Stock (OTCMKTS:SBLOF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get SBLOF alerts:Sign Up Key Stats Today's Range$6.87▼$7.0050-Day Range$7.00▼$7.0052-Week Range$7.00▼$9.16VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Shin Nippon Biomedical Laboratories Co., Ltd. (OTCMKTS:SBLOF) is a Japan-based contract research organization (CRO) that provides research and development support to pharmaceutical, biotechnology and other healthcare companies. Its services are designed to help clients evaluate the safety, effectiveness and development potential of drugs and other medical products. The company’s activities include nonclinical research, laboratory testing, bioanalysis, clinical trial support and related consulting services. SNBL works across areas such as pharmacology, toxicology and drug metabolism, supporting projects from early-stage discovery and preclinical evaluation through clinical development and regulatory preparation. Founded in Japan in 1957, Shin Nippon Biomedical Laboratories has developed an international operating presence serving clients in Japan and overseas. Its business includes research facilities and clinical-development capabilities, with operations and partnerships extending beyond its domestic market. The company is headquartered in Kagoshima, Japan.AI Generated. May Contain Errors. Read More Receive SBLOF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shin Nippon Biomedical Laboratories and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SBLOF Stock News HeadlinesShin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) Stock Short Interest Declines 64.0%October 12 at 8:00 AM | americanbankingnews.comSNBL Corrects Earnings Per Share Figure in Q1 FY2026 DisclosureAugust 5, 2026 | tipranks.comThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying out up to $1,152 a month to regular investors - no mining stocks, no options, no physical metal required. Chief Income Strategist Tim Plaehn calls it a breakthrough strategy that transforms gold's rally into reliable monthly payouts. The next distribution is just days away.October 13 at 1:00 AM | Investors Alley (Ad)Shin Nippon Biomedical 9-Mos Net Y2.27B Vs Net Y3.21BFebruary 7, 2026 | marketwatch.comShin Nippon Biomedical Laboratories Cuts Earnings Outlook Amid Profit Decline but Maintains Dividend PlanFebruary 5, 2026 | tipranks.comSNBL Cuts Full-Year Revenue and Operating Profit Outlook but Nudges Net Income Forecast HigherFebruary 5, 2026 | tipranks.comSNBL Releases Q3 FY2026 Results Briefing and Business UpdateFebruary 5, 2026 | tipranks.comSNBL warns of added costs as US migraine drug unit talks continueJanuary 5, 2026 | msn.comSee More Headlines SBLOF Stock Analysis - Frequently Asked Questions How have SBLOF shares performed this year? Shin Nippon Biomedical Laboratories' stock was trading at $10.03 on January 1st, 2026. Since then, SBLOF shares have decreased by 30.2% and is now trading at $7.00. How do I buy shares of Shin Nippon Biomedical Laboratories? Shares of SBLOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Life Sciences Tools & Services Sub-IndustryLife Sciences Tools & Services Current SymbolOTCMKTS:SBLOF CIKN/A Webwww.snbl.co.jp Phone81-3-5565-5001FaxN/AEmployees1,344Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (OTCMKTS:SBLOF) was last updated on 10/12/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shin Nippon Biomedical Laboratories, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Shin Nippon Biomedical Laboratories With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
